Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells

Carcinogenesis

Volumn 26, Issue 1, 2005, Pages 53-63

  Yih, Ling Huei ^a   Hsueh, Shun Wen ^a   Luu, Wei Shu ^c   Chiu, Ted H ^c   Lee, Te Chang ^b  

^a ACADEMIA SINICA   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; ATR PROTEIN; DOUBLE STRANDED DNA; NOCODAZOLE; PACLITAXEL; PROTEIN TYROSINE PHOSPHATASE;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL POPULATION; CELL SYNCHRONIZATION; CONTROLLED STUDY; CYTOTOXICITY; DNA CONTENT; DNA DAMAGE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MITOSIS INHIBITION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; X IRRADIATION;

APOPTOSIS; ARSENITES; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; G2 PHASE; GENES, CDC; HUMANS; MITOSIS; TERATOGENS;

EID: 13444263889     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh295     Document Type: Article

References (50)

1. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood, 89, 3354-3360.
2. Niu,C., Yan,H., Yu,T. et al. (1999) Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 94, 3315-3324.
3. Zhang,T.D., Chen,G.Q., Wang,Z.G., Wang,Z.Y., Chen,S.J. and Chen,Z. (2001) Arsenic trioxide, a therapeutic agent for APL. Oncogene 20, 7146-7153.
4. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood, 88, 1052-1061.
5. Zhu,X.H., Shen,Y.L., Jing,Y.K. et al. (1999) Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl Cancer Inst., 91, 772-778.
6. 3). FEBS Lett., 519, 195-200.
7. Ling,Y.H., Jiang,J.D., Holland,J.F. and Perez-Soler,R. (2002) Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol. Pharmacol., 62, 529-538.
8. Hyun Park,W., Hee Cho,Y., Won Jung,C., Oh Park,J., Kim,K., Hyuck Im,Y., Lee,M.H., Ki Kang,W. and Park,K. (2003) Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem. Biophys. Res. Commun., 300, 230-235.
9. Kanzawa,T., Kondo,Y., Ito,H., Kondo,S. and Germano, I. (2003) Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res., 63, 2103-2108.
10. Li,Y.M. and Broome,J.D. (1999) Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. Cancer Res., 59, 776-780.
11. Huang,S.C., Huang,C.Y.F. and Lee,T.C. (2000) Induction of mitosis-mediated apoptosis by sodium arsenite in HeLa S3 cells. Biochem. Pharmacol., 60, 771-780.
12. States,J.C., Reiners,J.J. Jr, Pounds,J.G., Kaplan,D.J., Beauerle,B.D., McNeely,S.C., Mathieu,P. and McCabe,M.J. Jr (2002) Arsenite disrupts mitosis and induces apoptosis in SV40-transformed human skin fibroblasts. Toxicol. Appl. Pharmacol., 180, 83-91.
13. Cai,X., Yu,Y., Huang,Y., Zhang,L., Jia,P.M., Zhao,Q., Chen,Z., Tong,J.H., Dai,W. and Chen,G.Q. (2003) Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells. Leukemia, 17, 1333-1337.
14. Huang,S.C. and Lee,T.C. (1998) Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells. Carcinogenesis, 19, 889-896.
15. Bhalla,K.N. (2003) Microtubule-targeted anticancer agents and apoptosis. Oncogene, 22, 9075-9086.
16. Mollinedo,F. and Gajate,C. (2003) Microtubules, microtubule-interfering agents and apoptosis. Apoptosis, 8, 413-450.
17. Hut,H.M., Lemstra,W., Blaauw,E.H., Van Cappellen,G.W., Kampinga,H.H. and Sibon,O.C. (2003) Centrosomes split in the presence of impaired DNA integrity during mitosis. Mol. Biol. Cell, 14, 1993-2004.
18. Takada,S., Kelkar,A. and Theurkauf,W.E. (2003) Drosophila checkpoint kinase 2 couples centrosome function and spindle assembly to genomic integrity. Cell, 113, 87-99.
19. Sampath,D. and Plunkett,W. (2001) Design of new anticancer therapies targeting cell cycle checkpoint pathways. Curr. Opin. Oncol. 13, 484-490.
20. Stanbridge,E.J., Der,C.J., Doersen,C.J., Nishimi,R.Y., Peehl,D.M., Weissman,B.E. and Wilkinson,J.E. (1982) Human cell hybrids: analysis of transformation and tumorigenicity. Science, 215, 252-259.
21. Stanbridge,E.J., Flandermeyer,R.R., Daniels,D.W. and Nelson-Rees,W.A. (1981) Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Genet., 7, 699-712.
22. Yih,L.H., Ho,J.C. and Lee,T.C. (1997) Sodium arsenite disturbs mitosis and induces chromosome loss in human fibroblasts. Cancer Res., 57, 5051-5059.
23. Stein,G.S. and Borun,T.W. (1972) The synthesis of acidic chromosomal proteins during the cell cycle of HeLa S-3 cells. I. The accelerated accumulation of acidic residual nuclear protein before the initiation of DNA replication. J. Cell Biol., 52, 292-307.
24. Laemmli,U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
25. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
26. Dong,J.T. and Luo,X.M. (1993) Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. Mutat. Res., 302, 97-102.
27. Wang,T., Hsu,T., Chung,C., Wang,A.S., Bau,D. and Jan,K. (2001) Arsenite induces oxidative DNA adducts and DNA-protein cross-links in mammalian cells. Free Radic. Biol. Med., 31, 321-330.
28. Wang,T.S., Chung,C.H., Wang,A.S., Bau,D.T., Samikkannu,T., Jan,K.Y., Cheng,Y.M. and Lee,T.C. (2002) Endonuclease III, formamidopyrimidine-DNA glycosylase and proteinase K additively enhance arsenic-induced DNA strand breaks in human cells. Chem. Res. Toxicol. 15, 1254-1258.
29. Schwerdtle,T., Walter,I., Mackiw,I. and Hartwig,A. (2003) Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis, 24, 967-974.
30. Shiloh,Y. (2003) ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer, 3, 155-168.
31. Sarkaria,J.N., Busby,E.C., Tibbetts,R.S., Roos,P., Taya,Y., Karnitz,L.M. and Abraham,R.T. (1999) Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res., 59, 4375-4382.
32. Matsuoka,S., Huang,M. and Elledge,S.J. (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science, 282, 1893-1897.
33. Chaturvedi,P., Eng,W.K., Zhu,Y. et al. (1999) Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene, 18, 4047-4054.
34. Liu,Q., Hilsenbeck,S. and Gazitt,Y. (2003) Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9 and synergy with APO2/TRAIL. Blood, 101, 4078-4087.
35. Yih,L.H. and Lee,T.C. (2003) Induction of C-anaphase and diplochromosome through dysregulation of spindle assembly checkpoint by sodium arsenite in human fibroblasts. Cancer Res., 63, 6680-6688.
36. Smits,V.A. and Medema,R.H. (2001) Checking out the G (2)/M transition. Biochim. Biophys. Acta, 1519, 1-12.
37. Iliakis,G., Wang,Y., Guan,J. and Wang,H. (2003) DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22, 5834-5847.
38. Yih,L.H. and Lee,T.C. (2000) Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res., 60, 6346-6352.
39. Park,J.W., Choi.Y.J., Jang,M.A., Baek,S.H., Lim,J.H., Passaniti,T. and Kwon,T.K. (2001) Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells. Biochem. Biophys. Res. Commun., 286 726-734.
40. Wahl,G.M. and Carr,A.M. (2001) The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat. Cell Biol., 3, E277-E286.
41. Bakkenist,C.J. and Kastan,M.B. (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature, 421, 499-506.
42. Senderowicz,A.M. (2003) Small-molecule cyclin-dependent kinase modulators. Oncogene, 22, 6609-6620.
43. Curman,D., Cinel,B., Williams,D.E. et al. (2001) Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine. J. Biol. Chem., 276, 17914-17919.
44. Den Elzen,N.R. and O'Connell,M.J. (2004) Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1. EMBO J. 23, 908-918.
45. Tsvetkov,L., Xu,X., Li,J. and Stern,D.F. (2003) Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J. Biol. Chem., 278, 8468-8475.
46. Xu,J. and Du,W. (2003) Drosophila chk2 plays an important role in a mitotic checkpoint in syncytial embryos. FEBS Lett., 545, 209-212.
47. Simeonova,P.P., Wang,S., Toriuma,W. et al. (2000) Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res., 60, 3445-3453.
48. Kitchin,K.T. (2001) Recent advances in arsenic carcinogenesis: modes of action, animal model systems and methylated arsenic metabolites. Toxicol. Appl. Pharmacol., 172, 249-261.
49. Miller,W.H. Jr, Schipper,H.M., Lee,J.S., Singer,J. and Waxman,S. (2002) Mechanisms of action of arsenic trioxide. Cancer Res. 62, 3893-3903.
50. Yih,L.H., Peck,K. and Lee,T.C. (2002) Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis, 23, 867-876.